novo nordisk glp-1 patent litigation How to bypass the lock How to Survive the GLP-1

Gamma-glutamyl transpeptidaseits role in hepatocarcinogenesis

There are two treatment trials in fibromyalgia patients using PEA as an OTC supplement to ongoing care

Access and Affordability Challenges The higher costs associated with peptide drugs can create access challenges, particularly in healthcare systems with limited resources or restrictive formulary policies

Patch test before first use and discontinue if irritation occurs

The end of 2026 is an inflection point, when 13 states have waivers expiring at once putting reentry services, HRSN, contingency management, uncompensated care pools and Tribal health services on the table simultaneously